To confirm tumor specificity, we assessed the mutation in the myeloid and B‐cell fraction by Sanger sequencing and found that IDH2, RHOA, CD28, and PLCγ1 were not detected in the myeloid and B‐cell fraction, but only in tumor fractions (Table S6, Figure S4F). Here, IDH2 is linked to neoplasm.